Some European countries have schemes allowing naloxone to be taken home by the drug user (EMCDDA, 2017(48)). A few countries have drug consumption rooms, where death from overdose is much less likely. Almost all countries have needle and syringe programmes, which can prevent the spread of infectious diseases, which can be very expensive to treat (such as hepatitis C).